Best quality 4-Fluorophenylboronic Acid - 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Intermediate Factory – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

With state-of-the-art technologies and facilities, strict good quality regulate, reasonable cost, exceptional assistance and close co-operation with prospects, we're devoted to supplying the top benefit for our customers for Weight 320.75, Glycidyl Butyrate, Trelagliptin Succinate CAS 1029877-94-8, Teamwork is encouraged at all levels with regular campaigns. Our research team experiments on various developments in the industry for improvement in the products.

Best quality 4-Fluorophenylboronic Acid - 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Intermediate Factory – Ruifu Detail:

Manufacturer Supply, High Purity, Commercial Production
Dapagliflozin (CAS: 461432-26-8) Related Intermediates:
5-Bromo-2-Chlorobenzoic Acid CAS 21739-92-4
5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS 32384-65-9

Chemical Name	5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane
Synonyms	4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene; 4-(5-Brom-2-Chlorbenzyl)phenyl-Ethylether; Dapagliflozin Bromo Impurity
CAS Number	461432-23-5
CAT Number	RF-PI447
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C15H14BrClO
Molecular Weight	325.63
Melting Point	41.0 to 43.0℃
Brand	Ruifu Chemical

Item	Specifications
Appearance	White to Pael Yellow Crystalline Powder
Purity / Analysis Method	≥99.0% (HPLC)
Water (K.F)	≤0.50%
Total Impurities	≤1.0%
Test Standard	Enterprise Standard
Usage	Intermediate of Dapagliflozin (CAS: 461432-26-8), type II diabetes

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene (CAS: 461432-23-5) is used as a intermediate in the synthesis of Dapagliflozin (CAS: 461432-26-8). Dapagliflozin is a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. Dapagliflozin is a new antidiabetic drug jointly developed by Bristol-Myers Squibb and AstraZeneca, being approved by the European Medicines Agency (EMA) on November 12, 2012. On January 8, 2014, the US Food and Drug Administration (FDA) have approved it for being used in the treatment of type II diabetes.

Product detail pictures:

Related Product Guide:

Being supported by an highly developed and specialist IT team, we could give technical support on pre-sales & after-sales service for Best quality 4-Fluorophenylboronic Acid - 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Intermediate Factory – Ruifu , The product will supply to all over the world, such as: Los Angeles, Czech, Mongolia, Our business activities and processes are engineered to make sure our customers have access to widest range of products with the shortest supply time lines. This achievement is made possible by our highly skilled and experienced team. We look for people who want to grow with us around the globe and stand out from the crowd. We now have people who embrace tomorrow, have vision, love stretching their minds and going far beyond what they thought was achievable.